GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (XSAT:EQL) » Definitions » Price-to-Tangible-Book

EQL Pharma AB (XSAT:EQL) Price-to-Tangible-Book

: 178.06 (As of Today)
View and export this data going back to 2013. Start your Free Trial

As of today (2024-04-18), EQL Pharma AB's share price is kr42.20. EQL Pharma AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was kr0.24. Hence, EQL Pharma AB's Price to Tangible Book Ratio of today is 178.06.

The historical rank and industry rank for EQL Pharma AB's Price-to-Tangible-Book or its related term are showing as below:

XSAT:EQL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.91   Med: 13.71   Max: 1021.05
Current: 175.83

During the past 11 years, EQL Pharma AB's highest Price to Tangible Book Ratio was 1021.05. The lowest was 3.91. And the median was 13.71.

XSAT:EQL's Price-to-Tangible-Book is ranked worse than
99.43% of 872 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs XSAT:EQL: 175.83

A closely related ratio is called PB Ratio. As of today, EQL Pharma AB's share price is kr42.20. EQL Pharma AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was kr5.95. Hence, EQL Pharma AB's P/B Ratio of today is 7.09.


EQL Pharma AB Price-to-Tangible-Book Historical Data

The historical data trend for EQL Pharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.69 20.97 - 67.39 27.56

EQL Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.42 27.56 21.29 18.14 140.93

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Price-to-Tangible-Book falls into.



EQL Pharma AB Price-to-Tangible-Book Calculation

EQL Pharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=42.20/0.237
=178.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


EQL Pharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (XSAT:EQL) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (XSAT:EQL) Headlines

From GuruFocus